Clearpoint Strategy Group’s engagements span from preclinical stage through product lifecycle management, and address each stage of corporate development. Our defined capabilities extend across all major therapeutic categories, including novel commercial products, generics/biosimilars, molecular diagnostics, and medical devices. We integrate seamlessly into collaborative projects, interfacing with internal client teams, as well as external partners and service providers.